Gabapentinoids related psychiatric disorders: an analysis based on the FAERS database from 2004 to 2023.
Authors
Li J, Dai Z, Zhang Z, Chen C, Xiong X, Xu F
Abstract
Gabapentinoids, including gabapentin and pregabalin, are commonly used for neuropathic pain but have safety concerns. This study analyzed U.S. Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS) data to assess risks of psychiatric disorders as adverse effects.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
